Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection
- 27 December 2018
- journal article
- conference paper
- Published by Wiley in The Laryngoscope
- Vol. 129 (6) , 1433-1437
Abstract
Objectives/Hypothesis: Vocal tremor is a neurologic disorder that can be treated with laryngeal botulinum toxin injections (LBTX). We sought to describe our experience with thyroarytenoid and concurrent strap muscle injection.Study Design: Retrospective chart review.Methods: A chart review was performed of all patients with a primary diagnosis of vocal tremor treated with LBTX from 2012 through 2017.Results: Twenty‐one patients were included (mean age 69 years, 100% female). Thirteen patients (62%) had a minor component of spasmodic dysphonia in addition to their tremor. Fourteen patients had vertical and horizontal components to their tremor, and two had horizontal tremor alone. The remaining five patients did not have clear characterization of their tremor. A total of 49 injections were reviewed (25 thyroarytenoid [TA], 24 thyroarytenoid and strap muscle [TA+S]), and patients reported subjective voice benefit with 48 (96%) of these (92% TA, 100% TA+S). When available, the postprocedural change from baseline Voice Handicap Index‐10 and Consensus Auditory Perceptual Evaluation of Voice scores were calculated (mean overall: −1.9, −7.8; TA: −2.7, −3.5; TA+S: −1.4, −10.3, respectively). Subjective patient improvement ratings (scale 0%–100%) were obtained for 46 injections, with a mean of 70% improvement per injection. Of patients with both horizontal and vertical tremor, outcomes were improved with TA+S injection versus TA alone (mean improvement 74% vs. 35%, P < .005).Conclusions: There is utility in the characterization of vertical and horizontal components of vocal tremor. Patients with both appear to have increased benefit with injection of strap muscles in addition to thyroarytenoid muscles.Level of Evidence: 4Laryngoscope, 129:1433–1437, 2019Keywords
This publication has 14 references indexed in Scilit:
- Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients: A Systematic ReviewOtolaryngology–Head and Neck Surgery, 2016
- Primidone Therapy for Essential Vocal TremorJAMA Otolaryngology–Head & Neck Surgery, 2016
- Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremorThe Laryngoscope, 2015
- A new paradigm for the management of essential vocal tremor with botulinum toxinThe Laryngoscope, 2013
- Coprevalence of tremor with spasmodic dysphoniaThe Laryngoscope, 2011
- Development of a Speech Treatment Program for a Client with Essential Vocal TremorSeminars in Speech and Language, 2011
- Laryngeal Tremor: Co-Occurrence with Other Movement DisordersORL, 2010
- Clinical characteristics of essential voice tremor: A study of 34 casesThe Laryngoscope, 2010
- Common Movement Disorders Affecting the Larynx: A Report from the Neurolaryngology Committee of the AAO‐HNSOtolaryngology–Head and Neck Surgery, 2005
- Botulinum Toxin Type A for Treating Voice TremorArchives of Neurology, 2004